Edwards Lifesciences Corporation reports results for the quarter ended September 30 - Earnings Summary

• Edwards Lifesciences Corporation EW.N reported quarterly adjusted earnings of 80 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 67 cents. The mean expectation of twenty five analysts for the quarter was for earnings of 74 cents per share. Wall Street expected results to range from 72 cents to 77 cents per share.

• Revenue rose 10.5% to $1.72 billion from a year ago; analysts expected $1.68 billion.

• Edwards Lifesciences Corporation's reported EPS for the quarter was 53 cents​.

• The company reported quarterly net income of $307.5 million.

• Edwards Lifesciences Corporation shares had risen by 10.3% this quarter and gained 11.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.1% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 26 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Edwards Lifesciences Corporation is $102.00, about 2.6% above its last closing price of $99.37

This summary was machine generated from LSEG data November 5 at 12:45 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)